Rosell R - Search Results

1

Targeting PKCι-PAK1 in EGFR-mutation positive non-small cell lung cancer.

Ito M, Codony-Servat C, Karachaliou N, Rosell R. Ito M, et al. Among authors: rosell r. Transl Lung Cancer Res. 2019 Oct;8(5):667-673. doi: 10.21037/tlcr.2019.08.25. Transl Lung Cancer Res. 2019. PMID: 31737502 Free PMC article.

2

A phase II study of days 1 and 8 cisplatin and recombinant alpha-2B interferon in advanced non-small cell lung cancer.

Rosell R, Carles J, Ariza A, Moreno I, Ribelles N, Solano V, Pellicer I, Barnadas A, Abad A. Rosell R, et al. Cancer. 1991 May 15;67(10):2448-53. doi: 10.1002/1097-0142(19910515)67:10<2448::aid-cncr2820671009>3.0.co;2-2. Cancer. 1991. PMID: 1707745 Clinical Trial.

3

Neuroendocrine differentiation as a prognostic factor in non-small cell lung cancer.

Carles J, Rosell R, Ariza A, Pellicer I, Sanchez JJ, Fernandez-Vasalo G, Abad A, Barnadas A. Carles J, et al. Among authors: rosell r. Lung Cancer. 1993 Dec;10(3-4):209-19. doi: 10.1016/0169-5002(93)90181-v. Lung Cancer. 1993. PMID: 7521264

4

K-ras gene point mutation: a stable tumor marker in non-small cell lung carcinoma.

Li S, Rosell R, Urban A, Font A, Ariza A, Armengol P, Abad A, Navas JJ, Monzo M. Li S, et al. Among authors: rosell r. Lung Cancer. 1994 Jul;11(1-2):19-27. doi: 10.1016/0169-5002(94)90279-8. Lung Cancer. 1994. PMID: 8081702

5

Drug resistance in non-small cell lung cancer.

Monzo M, Rosell R, Taron M. Monzo M, et al. Among authors: rosell r. Lung Cancer. 2001 Dec;34 Suppl 2:S91-4. doi: 10.1016/s0169-5002(01)00355-5. Lung Cancer. 2001. PMID: 11720748

6

DNA repair and cisplatin resistance in non-small-cell lung cancer.

Rosell R, Lord RV, Taron M, Reguart N. Rosell R, et al. Lung Cancer. 2002 Dec;38(3):217-27. doi: 10.1016/s0169-5002(02)00224-6. Lung Cancer. 2002. PMID: 12445742 Review.

7

Phase II non-randomized study of three different sequences of docetaxel and vinorelbine in patients with advanced non-small cell lung cancer.

Sánchez JM, Balañá C, Font A, Sánchez JJ, Manzano JL, Guillot M, Margelí M, Richardet M, Rosell R. Sánchez JM, et al. Among authors: rosell r. Lung Cancer. 2002 Dec;38(3):309-15. doi: 10.1016/s0169-5002(02)00220-9. Lung Cancer. 2002. PMID: 12445754 Clinical Trial.

8

Molecular markers and targeted therapy with novel agents: prospects in the treatment of non-small cell lung cancer.

Rosell R, Fossella F, Milas L; Spanish Lung Cancer Group. Rosell R, et al. Lung Cancer. 2002 Dec;38 Suppl 4:43-9. doi: 10.1016/s0169-5002(02)00171-x. Lung Cancer. 2002. PMID: 12480194 Review.

9

Genetic testing for chemotherapy in non-small cell lung cancer.

Rosell R, Taron M, Alberola V, Massuti B, Felip E. Rosell R, et al. Lung Cancer. 2003 Aug;41 Suppl 1:S97-102. doi: 10.1016/s0169-5002(03)00151-x. Lung Cancer. 2003. PMID: 12867068 Review.

10

Assessment of nucleotide excision repair XPD polymorphisms in the peripheral blood of gemcitabine/cisplatin-treated advanced non-small-cell lung cancer patients.

Camps C, Sarries C, Roig B, Sanchez JJ, Queralt C, Sancho E, Martinez N, Tarón M, Rosell R. Camps C, et al. Among authors: rosell r. Clin Lung Cancer. 2003 Jan;4(4):237-41. doi: 10.3816/clc.2003.n.004. Clin Lung Cancer. 2003. PMID: 14624713

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

841 results

Search Page

Filters